Cardiovascular Risks of Hydroxychloroquine vs Methotrexate in Patients With Rheumatoid Arthritis
Elvira D’Andrea, Rishi Desai, Mengdong He, Robert J. Glynn, Hemin Lee, Michael E. Weinblatt, Seoyoung C. Kim
Topics & Concepts
MedicineHydroxychloroquineRheumatoid arthritisMaceInternal medicineMyocardial infarctionMethotrexateCardiologyHazard ratioPercutaneous coronary interventionConfidence intervalDiseaseInfectious disease (medical specialty)Coronavirus disease 2019 (COVID-19)Rheumatoid Arthritis Research and TherapiesDrug-Induced Ocular ToxicityPharmacovigilance and Adverse Drug Reactions